← Eichor
Study identifier: NCT06878742 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants

Condition: Infant, Premature, Diseases · Circulatory and Respiratory Physiological Phenomena  ·  Sponsor: Instituto de Investigación Hospital Universitario La Paz

PhasePhase 1/Phase 2
Planned participants30
Who can joinAll sexes, N/A to 72 Hours
Healthy volunteersNo

About this study

Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).

This description comes directly from the study's public registry record.

Talk to the study team

Adelina Pellicer, MD  ·  917277416  ·  adelina.pellicer@salud.madrid.org

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital Universitario QuironsaludMadrid, SpainRecruiting
Hospital Universitario 12 de OctubreMadrid, SpainRecruiting
Hospital Universitario La PazMadrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06878742